Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115912
Revised: November 20, 2025
Accepted: December 23, 2025
Published online: March 15, 2026
Processing time: 134 Days and 20.1 Hours
Primary gastrointestinal lymphomas (PGIL) are rare tumors that can involve the whole gastrointestinal (GI) tract. Although lymphomas can originate from any part of the gastrointestinal tract, the most common sites are the stomach, small intestine, and ileocecal region.
To examine the clinicopathologic and prognostic features of PGIL.
We performed a retrospective single-center analysis of 111 patients diagnosed with gastrointestinal lymphomas (GIL) at Izmir Katip Celebi University Ataturk Training and Research Hospital. Histopathological, clinical, and prognostic para
The study included 111 patients diagnosed with GIL. The median age was 66 years (60 males, 51 females). Sites of involvement were stomach (67.5%), small bowel (18%), large bowel/rectum (12.6%), and pancreas (1.8%). Among 62 patients with primary GIL, 49 (79%) had diffuse large B-cell lymphoma (DLBCL), 6 (9.7%) had extranodal mar
In this study, the stomach was the most frequently involved site, DLBCL was the predominant subtype, and poor performance status was associated with poorer survival.
Core Tip: Primary gastrointestinal lymphoma (PGIL) is a rare and heterogeneous disease with diverse clinicopathologic and prognostic features. In this retrospective study of 62 primary cases, the stomach was the most frequently involved site, and diffuse large B-cell lymphoma was the predominant subtype. Poor performance status emerged as an independent predictor of reduced overall survival. This finding contributes to a better understanding of prognostic determinants in PGIL and may guide individualized management strategies in clinical practice.
